- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Ayurvedic drug 'Fifatrol' finds mention in compendium to tackle COVID-19
Fifatrol acts as an immunity enhancer which is a multi-drug combination of ayurvedic classical medicines and herbs
New Delhi: Fifatrol as an immunity-boosting ayurvedic drug has found a mention among around 200 technologies and research activities evaluated by experts in a recently released compendium for combating coronavirus. Compiled by the state-run National Research Development Corporation, the 'Compendium of Indian Technologies for Combating COVID-19 (Tracing, Testing &Treating)' provides the status of 200 indigenously developed technologies and ongoing research activities and efforts taken by the government to combat the deadly viral infection.
Health experts have suggested that boosting the body's immune system may help minimise the effects and hasten the recovery from the disease, the compendium stated.
"Prime Minister Narendra Modi, too, recently highlighted the benefits of Ayurveda and urged people to have a look at AYUSH Ministry's protocol to stay fit, saying good health is the harbinger of happiness.
"Fifatrol acts as an immunity enhancer which is a multi-drug combination of ayurvedic classical medicines and herbs. Researchers have suggested that Fifatrol acts as a natural antibiotic and fights infection, flu and ache," it stated.
Elaborating the salient features of the drug, the compendium stated that Fifatrol is a natural formulation providing fast relief from nasal congestion, sore throat, body ache and headache.
"It is enriched with scientifically validated botanical extracts and micro-nutrients. It is a rational combination of vital phytoconstituents, immunomodulators and antioxidants which justifies its beneficial effect for the treatment of viral upper respiratory infections," it said.
Fifatrol, developed by the AIMIL Pharma, is a formulation of well-known immunity enhancer herbs like 'Guduchi', 'Sanjeevini Ghanvati', 'Daruharidra', 'Apamarga', 'Chirayata', 'Karanja', 'Kutaki', Tulsi, 'Godanti' (Bhasam), 'Mrtyunjaya Rasa', 'Tribhuvana Kriti Rasa' and 'Sanjivani Vati'.
The drug offers an improved immune system in the top-notch form to fight off viral, bacterial and other infections; normalises raised body temperature, fastens recovery and eases the associated symptoms like flu, cold and congestion, the compendium stated.
The prime minister had urged AYUSH practitioners to pitch in to tackle the coronavirus pandemic. He has also been exhorting the citizens to fall back on traditional home remedies to boost their immunity amid the outbreak.
Read also: Clinical Trial Of Ayurvedic Medicine Zingivir-H Tablet Starts On COVID-19 Patients
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751